WHO ends mpox global health emergency; Senate panel passes suite of drug pricing bills

The WHO said that while mpox continues to spread internationally, steady progress has been made in controlling the outbreak.

May 11, 2023 Check out STAT+

Sponsored By

ERNESTO BENAVIDES/AFP via Getty Images WHO ends global health emergency over mpox Mpox — formerly known as monkeypox — is a disease caused by a poxvirus that triggers pox-like lesions on the skin and the mucus membranes. By Helen Branswell STAT+ | Senate panel passes a suite of drug pricing bills — but fails to advance one major PBM reform A Senate panel passed a package of bills aimed at speeding generic drug competition and reining in drug middlemen business practices. By John Wilkerson 'I don't see this as an end to the pandemic': Ashish Jha on the end of Covid public health emergency "I don't see this as an end to the pandemic or fighting Covid," White House Covid-19 Response Coordinator Ashish Jha said. By Ambar Castillo Adobe STAT+ | Scientists use 'mini-brains' to study microglia, the brain's cleanup crew and key players in neurological disease The authors found hints they could use "mini-brains" transplanted into mice to study human disease, including microglia's role in autism. By Jonathan Wosen STAT+ | Telework helps FDA compete for scientists. What if it's no longer an option? FDA's difficult task of hiring in-demand scientists could become even harder if federal workers must return to the office. By John Wilkerson Listen: Pharma vs. PBMs, Sarepta at the FDA, & a bold idea gone awry This episode, we explain why it's a massive week for Sarepta Therapeutics, the FDA, and the future of gene therapies for rare diseases. By Damian Garde and Meg Tirrell and Adam Feuerstein Adobe STAT+ | How the FDA's pandemic flexibilities boosted mental health apps — and what happens now STAT spoke to mental health app makers that took advantage of the FDA's loosened regulations during the pandemic about their future plans. By Mario Aguilar STAT+ | Wyden decries 'astonishingly low' tax rates for pharma companies as he probes business maneuvers "Big Pharma gets us coming and going - they charge Americans sky-high prices and they pay absolute rock-bottom taxes," said Sen. Ron Wyden By Ed Silverman

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Daily Recap? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2023, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser